MedPath

The effectiveness of a telerehabilitation exercise program in people with chronic liver disease

Not Applicable
Not yet recruiting
Conditions
Chronic Liver Disease
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Registration Number
ACTRN12623000167662
Lead Sponsor
Fiona Stanley Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Diagnosis of compensated chronic liver disease, Outpatient from Fiona Stanley Hospital, Access to appropriate technology for telehealth appointments which may include a computer/smart phone/tablet that can download the MS Teams app®

Exclusion Criteria

De-compensation of chronic liver disease, The American College of Sports Medicine’s contraindications to completing an exercise program, Musculoskeletal conditions that will make the exercise program painful (including severe rheumatoid arthritis, severe low back pain and acute injuries such as ligament sprains)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aerobic capacity as assessed by VO2 peak graded treadmill test (Modified Chronotropic Protocol).[Within 1 week before and after the intervention period];Strength as assessed by One repetition maximum chest press, leg press and hand dynamometry.[Within 1 week before and after the intervention period];Health-related quality of life as measured by the SF-12 Questionnaire<br><br>[Within 1 week before and after the intervention period]
Secondary Outcome Measures
NameTimeMethod
Anthropometry as assessed by the International Society for the Advancement of Kinanthropometry (ISAK) restricted profile. Skinfold testing will be completed using calipers and girth measurements using an anthropometric measuring tape.[Within 1 week before and after the intervention period.];Compliance as assessed by an exercise logbook. [Within 1 week after the intervention period];Liver Health as assessed by a Liver function blood test[Within 1 week before and after the intervention period];Liver stiffness/structure as assessed by Transient elastography (Fibroscan)[Within 1 week before and after the intervention period.];Exercise program acceptability as assessed by Barriers and Facilitators Questionnaire[Within 1 week after intervention period]
© Copyright 2025. All Rights Reserved by MedPath